Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Cisco who wrote (1340)	1/31/1998 3:40:00 PM
From: Frank Buck	Respond to of 1894

Cisco, AutoCyte lists a 501 PMA for an Image Titer workstation for antinuclear antibodies using an indirect immunofluorescent assay test kit that tests for ANA IFA. Sounds like ACYT used a pinch of this technology and a pinch of that technology so they wouldn't miss anything. What is a ANA IFA and what are they testing it for?? AutoCyte also lists a DNA ploidy measurement system. It is nice to know that AccuMed won't be in competition with strangers. AutoCyte has their finger in everyones pie. Monolayer systems, DNA measurement, immunofluorescent assays, antinuclear antibodies... heck I am selling ACMI and buying ACYT.<g> You know who.